Composition of matter patents maintained in U.S., Europe, China
U.S. patents granted – silsesquioxanes, elastomers, drug
Trademarks received U.S., Europe, China, India, and Brazil
K21 QAS DRUG
FDA Drug Master file K21 QAS DRUG
FDA NDA 128706 K21 QAS DRUG Topical Antimicrobial
FDA cleared medical devices
FDA Device Master file with K21 QAS
FDA Device Master file with K18 QAMS
FiteBac Presents in Germany at International Dental Show
U.S.-Based FiteBac Presents in Germany for First Time at International Dental Show, IDS2021, to Feature New Antimicrobial Additives for Dental Restorative MaterialsSummary: FiteBac will be a new, featured presenter at the world’s largest dental conference, IDS 2021,...
FiteBac Technology and Siltech team up to manufacture novel antimicrobial silsesquioxanes with advanced properties.
Summary: After the successful launch of multiple FDA-cleared antimicrobial dental devices, FiteBac partners with Siltech, an international corporation specializing in innovative silicone products, to develop novel materials imbued with FiteBac’s broad antimicrobial...
FiteBac Dental, RDAbbott Team Up for Advanced Products in Medical, Dental
FiteBac, manufacturer of patented antimicrobial compounds and additives for dentistryand medicine, announces partnership with RDAbbott to provide non-leaching, durableand persistent bactericidal, fungicidal, and virucidal protection in synthetic and siliconerubbers....